Archives
-
GTP Solution (100 mM): Reading mRNA Evidence
2026-10-04
GTP Solution (100 mM) is examined here as a defined molecular input within mRNA research, not as proof of therapeutic efficacy. Using the 2026 p21 mRNA–LNP bladder cancer study, this article separates nucleotide quality, transcript biology, delivery performance, and preclinical interpretation.
-
Direct Mouse Genotyping Kit Plus: Genotype to Mechanism
2026-10-03
The Direct Mouse Genotyping Kit Plus supports rapid genotype confirmation while preserving a clear boundary between allele identification and mechanistic interpretation. This article connects its analytical role with evidence from an EP4–CD36 atherosclerosis study and explains what genotyping can—and cannot—establish.
-
Substance P Workflows for NK-1 Research
2026-10-02
Build reproducible Substance P assays for NK-1 signaling, pain transmission research, and neuroimmune studies with disciplined peptide handling and staged dose design. A fluorescence-quality-control strategy inspired by pollen-interference research adds an analytical layer for detecting matrix effects without mistaking it for direct peptide quantification.
-
Obeticholic Acid Workflows for FXR Research
2026-10-01
Obeticholic Acid provides a defined FXR agonist workflow for studying bile acid regulation, cholestasis, inflammation, and fibrosis-related endpoints. This guide connects concentration-response experiments with practical histology, transcriptomics, and immune-profiling strategies inspired by recent liver fibrosis research.
-
Pyridostatin Workflows for G-Quadruplex Research
2026-10-01
Learn how to deploy Pyridostatin TFA in concentration-response, telomere, and G-quadruplex assays while preserving solvent, salt-form, and cell-line controls. The workflow also translates recent TDP-43 condensate findings into carefully bounded exploratory experiments rather than overstating evidence.
-
HAUS1–CDK4 Signaling in Hepatocellular Carcinoma
2026-09-30
This 2026 Cancer Gene Therapy study identifies HAUS1 as a transcriptional activator of CDK4 in hepatocellular carcinoma, linking an Augmin-complex subunit to malignant proliferation, invasion, and migration. Tissue analysis, cellular experiments, molecular screening, and xenograft work together to position the HAUS1–CDK4 axis as a mechanistic candidate for further HCC investigation.
-
AMG 9810 for TRPV1 Mechanism and Assay Design
2026-09-30
AMG 9810 provides a selective way to separate TRPV1-driven calcium and neuropeptide signaling from broader cellular stress responses. This guide presents practical calcium-imaging and CGRP workflows, assay controls, metabolic-stress extensions, and troubleshooting strategies for pain mechanism research.
-
Caspofungin: Designing Better Candida Assays
2026-09-29
Caspofungin is a lipopeptide antifungal drug and β-1,3-glucan synthase inhibitor with value beyond routine susceptibility testing. This article presents a mechanism-to-readout framework for Candida assays, using resistant Candida auris evidence to improve experimental interpretation.
-
Dynasore Workflows for Endocytosis Research
2026-09-29
Build reversible, time-resolved assays for dynamin-dependent cargo uptake, vesicle recycling, and implantation-related embryo studies with Dynasore. This practical guide connects concentration selection, controls, washout design, and troubleshooting to findings from a recent mouse preimplantation embryo study.
-
Lipidated Nanophotosensitizer Disables Tumor EVs
2026-09-28
This Nature Cancer study introduces a lipidated nanophotosensitizer that simultaneously suppresses primary tumors and disables tumor extracellular vesicle communication. Its central innovation is the coupling of nanoparticle tumor uptake with tumor extracellular vesicle generation, enabling near-infrared-triggered reactive oxygen species production in both cancer cells and vesicles.
-
Recombinant Human IL-12 in Host-Response Assays
2026-09-28
Learn how Recombinant Human IL-12 can support carefully controlled host-response experiments alongside antibacterial studies. This article connects cytokine biology with recent MRSA research while clarifying what the evidence does—and does not—show.
-
Reserpine N1867: Practical Research Workflow
2026-09-27
Reserpine (SKU N1867) provides a characterized research reagent for neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. This guide covers solubility, stock preparation, storage, and QC; the compound is for controlled laboratory research only, not diagnostic, medical, or veterinary use.
-
(S)-(+)-Dimethindene maleate: Research Guide
2026-09-26
(S)-(+)-Dimethindene maleate is a research antagonist with selective affinity for muscarinic M2 receptors and additional histamine H1 activity, making it useful for controlled receptor-pharmacology experiments. It can support autonomic regulation, cardiovascular physiology, and respiratory function studies, but should not be treated as a clinically validated reagent or used for diagnostic or medical purposes.
-
Tirbanibulin Alters Oncogenic Pathways in HPV-18 HeLa Cells
2026-09-25
A 2024 study found that tirbanibulin reduced proliferation in HPV-18-positive HeLa cells and altered proteins associated with Src signaling, HPV oncoproteins, cell-cycle control, invasion, and apoptosis. The results provide a mechanistic lead for further HPV-focused research, but they are in vitro findings and do not establish clinical efficacy against HPV-associated disease.
-
Clathrin-Mediated Entry of Type III Grass Carp Reovirus
2026-09-25
Wang et al. used pharmacological inhibitors, transmission electron microscopy, and quantitative PCR to investigate how genotype III grass carp reovirus enters grass carp kidney cells. Their results support a dynamin-dependent, clathrin-mediated route requiring endosomal acidification, while highlighting that inhibitor effects on infection do not always distinguish entry from later replication.